Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas with limited therapeutic options. Loss of the Polycomb repressive complex 2 (PRC2), via inactivating mutations in SUZ12 or EED, occurs frequently in MPNSTs and is associated with poor prognosis. However, the downstream chromatin and signaling consequences of these mutations remain incompletely understood. Here, we show that PRC2 deficiency in MPNST cells…
Integrated Proteomic and Epigenomic Analysis Reveals IGF2 as a Vulnerability in PRC2-Deficient Malignant Peripheral Nerve Sheath Tumors
bioRxiv Cancer Biology | | Lempiainen, J. K., Miachin, K., Liu, X., Yang, K., Horth, C., Bareke, E., Grinwald, M. F., Saintilnord, W. N., Wang, T., Majewski, J., Hirbe, A. C., Garcia, B. A.
Topics: sarcoma, research